Sequana Medical NV
SQNMF
$3.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | 0.00% | -98.57% | |||
| Gross Profit | 0.00% | -100.47% | |||
| SG&A Expenses | -3.04% | -4.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -2.94% | 202.09% | |||
| Total Operating Expenses | -3.04% | -4.05% | |||
| Operating Income | 3.04% | 3.00% | |||
| Income Before Tax | 3.04% | -212.36% | |||
| Income Tax Expenses | -3.10% | -5.48% | |||
| Earnings from Continuing Operations | 3.04% | -209.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.04% | -209.50% | |||
| EBIT | 3.04% | 3.00% | |||
| EBITDA | 3.04% | 3.28% | |||
| EPS Basic | 3.03% | -143.35% | |||
| Normalized Basic EPS | 3.04% | -145.56% | |||
| EPS Diluted | 3.03% | -143.35% | |||
| Normalized Diluted EPS | 3.04% | -145.56% | |||
| Average Basic Shares Outstanding | 0.00% | 27.19% | |||
| Average Diluted Shares Outstanding | 0.00% | 27.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||